-
Diagnostics World | It is notoriously difficult to detect ovarian cancer early, particularly aggressive high-grade serous types that often originate as precursor lesions in the fallopian tubes. The cancer quietly spreads at a microscopic level within the abdomen, defying discovery until symptoms emerge in advanced stages of the disease when it becomes hard to treat and difficult to cure.
Apr 22, 2026
-
Diagnostics World | Early dementia with Lewy bodies (DLB) and early Parkinson’s disease share several symptoms and are often misdiagnosed in early stages. It is critical to accurately distinguish the two diseases because of their contrasting disease paths. Fortunately, walking behaviors may be early diagnostic markers for neurodegeneration.
Apr 17, 2026
-
Diagnostics World | Labcorp and the Children’s Hospital of Philadelphia (CHOP) announced this week that they will be entering a collaboration to advance the discovery and development of specialized pediatric diagnostics, as well as expand access to advanced diagnostic testing for children and families across the nation.
Apr 16, 2026
-
Diagnostics World | Researchers in Belgium compared cognition to movement data in healthy adults looking for links that might predict cognitive decline later in life. The study is part of the PASOCA-project (how Physical Activity and Sleep relate to Optimal Cognitive Ageing), a two-year longitudinal, observational study examining 24-hour movement behaviors and cognitive function in cognitively healthy adults aged 55 and older residing in Flanders, Belgium.
Apr 14, 2026
-
Diagnostics World | New research released in pre-print from npj Breast Cancer digs deeper into the racial disparities of breast cancer and how the MammaPrint and BluePrint genomic tests from Agendia handle the differences.
Apr 10, 2026
-
Diagnostics World | New research released in pre-print from npj Breast Cancer digs deeper into the racial disparities of breast cancer and how the MammaPrint and BluePrint genomic tests from Agendia handle the differences.
Apr 10, 2026
-
Diagnostics World | When Web Golinkin joined Babson Diagnostics as an advisor in mid-2024, he did what experienced healthcare executives do: he listened, watched, and formed a thesis. After eight months advising, a brief stint as president and chief commercial officer, and now one month into the CEO role, his thesis has hardened into conviction.
Apr 9, 2026